acut
gastroenter
age
case
remain
etiolog
undiagnos
main
aim
determin
appropri
list
enter
pathogen
includ
daili
diagnost
scheme
age
ensur
lowest
possibl
diagnost
gap
children
year
age
admit
hospit
slovenia
octob
octob
age
year
old
healthi
children
includ
studi
broad
spectrum
enter
pathogen
target
molecular
method
includ
virus
bacteria
parasit
resultsat
least
one
enter
pathogen
detect
case
age
control
virus
preval
follow
bacteria
parasit
case
control
respect
high
proport
mix
infect
observ
case
case
undetermin
etiolog
stool
sampl
analyz
next
gener
sequenc
potenti
viral
pathogen
detect
addit
sampl
conclusionsour
studi
suggest
test
rotavirus
norovirus
genogroup
ii
adenovirus
astrovirus
campylobact
spp
salmonella
sp
includ
initi
diagnost
algorithm
reveal
etiolog
children
test
use
molecular
method
diagnost
gastroenter
prefer
high
sensit
specif
fast
perform
possibl
establish
concentr
target
latter
may
valuabl
assess
clinic
signific
detect
enter
particularli
viral
pathogen
acut
gastroenter
age
remain
import
caus
mortal
among
children
worldwid
age
children
rang
third
place
caus
mortal
neonat
diseas
pneumonia
mani
differ
pathogen
includ
virus
bacteria
parasit
associ
age
preval
vari
among
world
region
enter
virus
among
import
pathogen
contribut
high
diseas
burden
develop
develop
region
systemat
review
age
mortal
children
reveal
four
major
pathogen
rotavirus
calicivirus
enteropathogen
enterotoxigen
escherichia
coli
account
half
age
death
children
year
age
world
develop
countri
mortal
age
low
incid
infecti
diarrhea
remain
high
despit
better
hygien
condit
countri
virus
preval
bacteri
pathogen
howev
last
year
rotaviru
vaccin
contribut
signific
reduct
diseas
burden
especi
countri
high
vaccin
coverag
environ
substanti
decreas
rotaviru
diseas
overal
age
case
note
increas
consequ
rel
import
enter
pathogen
age
previou
studi
reveal
variabl
proport
etiolog
undiagnos
age
case
diagnost
gap
might
suggest
pathogen
alreadi
diagnos
could
contribut
overal
diseas
burden
rate
etiolog
undiagnos
age
case
vari
among
publish
report
even
higher
nonpediatr
popul
newli
develop
method
enabl
syndrom
approach
diagnost
age
effici
decreas
etiolog
undiagnos
case
time
increas
proport
detect
mix
infect
main
aim
casecontrol
studi
profil
import
pathogen
associ
sever
case
age
children
determin
narrow
diagnost
gap
improv
diagnost
approach
ambit
optim
manag
case
use
broad
rang
molecular
test
subsequ
new
molecular
techniqu
next
gener
sequenc
ng
screen
undiagnos
case
age
unspecifi
less
frequent
viral
target
clinic
import
pathogen
also
evalu
casecontrol
studi
conduct
univers
medic
centr
ljubljana
depart
infecti
diseas
depart
paediatr
surgeri
intens
care
etiolog
age
use
broad
spectrum
detect
method
virus
bacteria
parasit
univers
medic
centr
locat
ljubljana
capit
slovenia
cover
central
slovenian
region
approxim
inhabit
children
year
age
http
wwwstatsistatwebenhom
area
highest
popul
densiti
includ
capit
urban
popul
smaller
settlement
rural
part
also
intens
agricultur
enrol
phase
studi
start
octob
th
complet
octob
th
two
group
children
six
year
age
parent
consent
obtain
includ
studi
patient
age
age
group
control
group
children
age
defin
pass
loos
stool
least
three
time
within
last
hour
without
vomit
last
day
hospit
depart
infecti
diseas
control
group
compris
children
hospit
depart
paediatr
surgeri
intens
care
elect
surgic
procedur
without
clinic
sign
acut
gastroenter
least
day
prior
procedur
day
discharg
hospit
inform
sign
age
obtain
questionnair
oper
children
famili
member
stool
sampl
collect
age
case
control
one
sampl
per
enrol
subject
immedi
admiss
sent
institut
microbiolog
immunolog
faculti
medicin
univers
ljubljana
microbiolog
examin
approv
studi
obtain
slovenian
nation
medic
ethic
committe
nr
sever
ill
children
age
assess
use
vesikari
score
paramet
use
score
system
includ
durat
day
diarrhea
maximum
number
diarrhea
episod
period
durat
day
vomit
maximum
number
vomit
episod
period
maximum
fever
degre
dehydr
manag
nil
outpati
manag
hospit
paramet
point
given
maximum
score
age
episod
vesikari
score
classifi
sever
parent
children
age
contact
phone
month
discharg
hospit
collect
data
cours
ill
discharg
hospit
requir
calcul
vesikari
score
stool
sampl
prepar
suspens
pb
ph
use
dna
extract
qiaamp
stool
mini
kit
qiagen
valencia
ca
molecular
detect
enter
bacteri
parasit
pathogen
detect
enter
virus
stool
suspens
centrifug
minut
follow
minut
separ
clear
supernat
bacteria
biolog
materi
follow
nucleic
acid
extract
iprep
automat
extractor
use
viral
nucleic
acid
kit
life
technolog
foster
citi
ca
nucleic
acid
use
immedi
store
use
ng
applic
stool
suspens
vortex
vigor
zirconiasilica
bead
centrifug
min
supernat
treat
nucleas
elimin
noncapsul
nucleic
acid
nucleas
treatment
supernat
filter
use
u
filter
incub
rnase
mgml
life
technolog
minut
room
temperatur
rnase
treatment
turbo
dnase
life
technolog
benzonas
ku
novagen
san
diego
ca
ad
reaction
incub
room
temperatur
minut
viral
nucleic
acid
extract
nucleas
treat
stool
suspens
use
nuclisen
easymag
isol
protocol
biomerieux
durham
nc
follow
extract
rnase
life
technolog
ad
extract
nucleic
acid
sampl
detect
common
bacteri
pathogen
stool
sampl
also
inocul
blood
agar
plate
xylos
lysin
deoxychol
xld
plate
directli
enrich
selenitef
broth
karmali
plate
blood
agar
xld
plate
selenit
fbroth
incub
hour
normal
atmospher
karmali
plate
hour
microaerophil
condit
suspect
coloni
specif
enter
bacteria
agar
plate
character
speci
level
microflex
lt
malditof
ms
bruker
dalton
billerica
usa
stool
sampl
screen
preval
bacteri
viral
parasit
agent
list
agent
select
test
scheme
prepar
basi
previou
find
public
european
countri
report
gastroenter
etiolog
young
children
detect
agent
inhous
rt
qpcr
protocol
implement
viral
panel
group
rotavirus
rov
adenovirus
speci
f
advf
genogroup
ii
norovirus
novi
novii
human
astrovirus
hastv
human
sapovirus
hsav
human
bocavirus
iiv
hbovihboviv
human
coronavirus
hcov
parechovirus
pev
test
use
amplif
protocol
refer
public
bacteri
panel
campylobact
spp
salmonella
sp
yersinia
sp
shigella
sp
clostridium
difficil
includ
follow
alreadi
describ
publish
protocol
among
parasit
cryptosporidium
spp
giardia
duodenali
includ
also
use
molecular
method
describ
previou
public
viral
target
amplifi
realtim
pcr
machin
life
technolog
use
onestep
rtpcr
reagent
life
technolog
platinum
quantit
pcr
supermixudg
rox
invitrogen
carlsbad
ca
usa
exclus
potenti
asymptomat
carrier
specif
virus
cycl
threshold
ct
valu
distribut
target
preval
rov
advf
novii
pev
shown
histogram
ct
distribut
sinc
ct
valu
depend
target
concentr
also
use
comparison
differ
target
multipl
viral
infect
amplif
campylobact
spp
salmonella
sp
yersinia
sp
shigella
sp
target
gene
perform
use
lightcycl
faststart
dna
master
plu
hybprob
roch
appli
scienc
lightcycl
platform
roch
appli
scienc
detect
c
difficil
gene
encod
toxin
b
tcda
tcdb
done
use
taqman
fast
viru
master
mix
life
technolog
fast
realtim
pcr
system
life
technolog
determin
diarrheagen
group
e
coli
screen
presenc
gene
list
perform
mix
bacteri
cultur
grown
primari
blood
agar
plate
case
posit
pcr
result
least
coloni
subcultur
primarycultur
plate
retest
obtain
isol
posit
test
gene
coloni
equal
volum
mix
microbi
cultur
approxim
one
loop
microbi
cultur
pick
resuspend
te
buffer
sigmaaldrich
st
loui
mo
suspens
heat
min
centrifug
min
supernat
use
molecular
detect
diarrheagen
group
e
coli
target
gene
verocytotoxinproduc
e
coli
vtec
eae
gene
enteropathogen
e
coli
epec
vtec
strain
elta
esta
gene
enterotoxigen
e
coli
etec
ipah
gene
enteroinvas
e
coli
eiec
aat
aap
aggr
aap
gene
enteroaggreg
e
coli
eaggec
detect
serogroup
perform
accord
instruct
antisera
produc
staten
serum
institut
denmark
sifin
germani
denka
seiken
japan
intimin
posit
e
coli
isol
serogroup
classic
newli
recogn
epec
h
serotyp
interpret
epec
stool
sampl
pathogen
detect
screen
includ
metagenom
analysi
detect
possibl
new
newli
emerg
virus
extract
nucleic
acid
prepar
ng
applic
revers
transcrib
use
random
primer
superscript
iii
revers
transcript
kit
life
technolog
rnase
h
treatment
life
technolog
second
dna
strand
synthes
klenow
fragment
life
technolog
dna
purifi
use
dna
librari
prepar
life
technolog
purifi
librari
load
onto
iontorr
chip
sequenc
iontorr
pgm
machin
life
technolog
sequenc
obtain
ng
analyz
use
geneiou
softwar
biomatt
ltd
new
zeland
detect
rate
individu
pathogen
age
control
group
compar
chisquar
test
fisher
exact
test
two
test
also
use
comparison
clinic
paramet
children
age
accord
detect
pathogen
order
assess
differ
mean
ct
valu
age
case
control
group
use
independ
sampl
ttest
pathogen
addit
viru
proport
confid
interv
multipl
infect
specif
viral
pathogen
lower
viral
load
codetect
virus
calcul
comparison
p
valu
indic
statist
signific
statist
analys
perform
use
ibm
spss
version
consent
inclus
studi
obtain
children
age
children
control
group
howev
stool
sampl
obtain
children
age
control
group
particip
patient
includ
studi
main
reason
unsuccess
sampl
children
age
discharg
hospit
short
period
time
rehydr
ie
prior
defec
obtain
specimen
age
group
control
group
differ
averag
age
versu
month
malefemal
ratio
patient
age
control
group
p
enrol
age
case
highest
march
may
altogeth
children
includ
enrol
control
group
show
less
stabl
pattern
throughout
studi
enrol
period
children
includ
control
group
questionnair
appear
diarrhea
within
day
discharg
hospit
return
particip
none
report
diarrhea
subgroup
questionnair
obtain
subgroup
request
inform
avail
differ
significantli
term
sex
age
use
broad
rang
molecular
test
least
one
agent
detect
children
age
control
group
particip
fig
tabl
detect
rate
viral
bacteri
parasit
agent
stool
sampl
togeth
mean
ct
valu
obtain
rt
qpcr
age
control
group
present
group
preval
agent
virus
follow
bacteria
parasit
one
agent
demonstr
sever
children
among
virus
rov
novii
adv
hastv
pev
significantli
often
detect
age
control
group
among
bacteria
campylobact
sp
salmonella
sp
show
detect
differ
studi
group
preval
parasit
low
enabl
reliabl
statist
analysi
tabl
proport
mix
infect
age
group
high
complex
mixtur
agent
identifi
preval
combin
presenc
one
viru
combin
virusbacteria
fig
pattern
copres
term
specif
pathogen
combin
although
pev
hsav
frequent
viral
combin
nucleic
acid
sequenc
potenti
viral
pathogen
detect
test
specimen
ng
analysi
tabl
case
nucleotid
sequenc
virus
includ
miss
test
method
obtain
hsav
pev
nov
nov
pev
nov
stool
specimen
virus
encompass
basic
test
demonstr
includ
specif
enteroviru
sequenc
specimen
human
astv
mlb
sampl
human
adv
speci
c
sampl
picobirnaviruslik
sequenc
sampl
last
name
probabl
repres
distant
variant
current
publish
picobirnaviru
sinc
deduc
amino
acid
sequenc
ident
found
blastx
search
genbank
ident
picobirnaviru
found
turkey
faec
ad
ng
result
previou
list
detect
agent
overal
detect
rate
age
group
achiev
howev
mani
case
high
ct
valu
indic
low
target
concentr
tabl
highest
preval
major
viral
agent
children
age
age
group
month
fig
howev
sever
except
preval
advf
highest
age
group
month
declin
undetect
children
month
old
contrast
preval
novii
highest
children
month
age
detect
peak
rov
age
group
month
sever
viral
target
specif
agerel
trend
observ
among
bacteria
pathogen
e
coli
c
difficil
frequent
detect
patient
age
none
significantli
higher
preval
age
control
group
within
e
coli
posit
sampl
children
age
eaggec
detect
epec
vtec
eteceaggec
epec
eaggec
sampl
e
coli
present
singl
pathogen
posit
age
sampl
addit
intimin
eae
gene
detect
e
coli
isol
obtain
children
age
isol
obtain
control
group
isol
belong
classic
newli
recogn
epec
although
c
difficil
detect
age
group
detect
singl
pathogen
age
posit
case
mean
ct
valu
also
sever
score
significantli
higher
case
c
difficil
co
infect
comparison
case
pathogen
tabl
median
age
children
demonstr
c
difficil
month
highest
preval
age
group
month
preval
declin
increas
age
c
difficil
posit
children
older
month
c
difficil
posit
sampl
control
group
infant
month
age
standard
cultur
method
bacteria
less
sensit
molecular
method
detect
rate
versu
age
case
versu
control
group
look
specif
pathogen
standard
cultur
method
fail
identifi
e
coli
posit
sampl
salmonella
posit
sampl
campylobact
posit
sampl
one
shigella
posit
sampl
also
miss
standard
method
c
difficil
specif
molecular
diagnost
procedur
use
cryptosporidium
spp
giardia
duodenali
detect
rare
tabl
cryptosporidium
spp
found
children
age
pathogen
c
parvum
predomin
cryptosporidium
speci
case
respect
c
parvum
also
detect
child
control
group
singl
g
duodenali
posit
sampl
codetect
rotavirus
establish
compar
age
control
group
signific
differ
preval
found
test
agent
tabl
addit
stool
patient
age
one
agent
often
present
ct
valu
virus
fairli
high
exampl
major
pev
sever
repres
virus
tabl
significantli
lower
mean
ct
valu
age
control
group
found
rotaviru
virus
tabl
accord
vesikari
score
measur
age
sever
signific
differ
among
pathogen
although
rov
salmonella
sp
e
coli
case
present
slightli
higher
mean
sever
score
pathogen
tabl
giardia
duodenali
one
posit
case
rov
coinfect
note
high
vesikari
score
assess
individu
clinic
paramet
reveal
salmonella
case
often
present
higher
fever
longer
durat
diarrhoea
day
children
campylobact
infect
found
significantli
frequent
group
without
vomit
contrast
rov
infect
tabl
copres
one
agent
associ
sever
diseas
regardless
type
coinfect
virusviru
virusbacteria
number
detect
pathogen
one
four
sinc
mani
case
possibl
differenti
bacteri
viral
enter
infect
clinic
laboratori
diagnost
strategi
determin
etiolog
reason
time
crucial
manag
patient
howev
comprehens
studi
etiolog
age
hospit
children
slovenia
target
three
major
pathogen
group
virus
bacteria
parasit
diagnost
scheme
report
present
casecontrol
studi
virus
bacteria
andor
parasit
found
stool
specimen
obtain
children
age
use
broad
rang
molecular
test
addit
case
use
ng
result
diagnosi
case
ng
import
tool
pathogen
discoveri
sinc
mani
new
emerg
virus
alreadi
success
detect
method
case
ng
provid
import
inform
viral
pathogen
either
detect
exist
method
repres
potenti
new
enter
pathogen
appear
molecular
test
astv
updat
addit
detect
least
viral
variant
astvmlb
found
sampl
screen
ng
detect
potenti
novel
picobirnavirus
also
taken
consider
evalu
role
etiolog
age
agreement
previou
report
europ
present
studi
determin
virus
common
caus
gastroenter
among
children
year
age
rov
frequent
viru
found
rel
low
proport
norovirus
recogn
caus
age
patient
need
hospit
surpris
mostli
found
older
children
adult
shown
countri
high
rotaviru
vaccin
coverag
austria
finland
belgium
vaccin
effect
prevent
sever
case
age
drastic
decreas
hospit
rate
diarrhea
signific
reduct
rovrel
overal
age
incid
may
consequ
result
higher
rel
import
nov
age
howev
slovenia
rov
vaccin
avail
recommend
sinc
children
fulli
vaccin
proport
even
lower
nation
institut
public
health
slovenia
vaccin
coverag
countri
probabl
low
major
epidemiolog
chang
age
could
associ
minor
chang
rov
epidemiolog
observ
introduct
vaccin
sinc
presenc
microb
stool
confirm
causal
associ
age
tri
assess
clinic
signific
inclus
control
group
children
without
diarrhea
measur
microorgan
burden
stool
specimen
semiquantit
pcr
assay
low
ct
valu
indic
high
burden
vice
versa
latter
approach
base
premis
chanc
causal
relationship
greater
higher
burden
lower
burden
viral
target
detect
stool
specimen
rov
novii
adv
astv
pev
significantli
frequent
patient
age
control
group
without
diarrhea
tabl
find
suggest
role
virus
question
probabl
clinic
import
pathogen
children
year
old
hospit
age
result
also
corrobor
previou
report
indic
cov
hsav
bov
rare
found
children
year
old
hospit
age
suggest
causal
relationship
sever
virus
detect
present
studi
age
question
conclus
support
fairli
high
ct
valu
virus
find
significantli
lower
mean
ct
valu
age
control
group
found
rotaviru
virus
tabl
probabl
valid
also
pev
even
though
rank
second
common
viru
demonstr
stool
specimen
found
often
patient
age
control
patient
low
viral
burden
compar
found
control
group
frequent
copres
potenti
etiolog
agent
age
reliabl
support
clinic
signific
tabl
accord
literatur
role
pev
age
complet
elucid
author
support
etiolog
role
pev
gastroenter
especi
genotyp
other
report
detect
pev
stool
irrespect
clinic
present
novi
hsav
cov
pev
thu
need
includ
routin
diagnost
approach
hospit
children
year
old
age
howev
might
differ
rel
frequenc
enter
pathogen
variou
geograph
region
world
suggest
need
appropri
evalu
relev
diagnost
list
enter
pathogen
bacteri
pathogen
much
less
preval
virus
age
find
expect
agre
result
europ
usa
australia
bacteri
pathogen
shown
contribut
gastroenter
case
age
group
present
studi
c
jejunicoli
salmonella
sp
found
significantli
often
children
age
control
person
e
coli
c
difficil
report
previous
small
children
frequent
colon
c
difficil
provid
potenti
reservoir
toxigen
strain
c
difficil
import
factor
pathogen
circul
present
studi
detect
rate
highest
among
infant
month
low
children
month
old
age
pattern
corrobor
previou
report
clue
dubiou
etiolog
role
c
difficil
small
children
age
find
c
difficil
detect
sole
agent
stool
specimen
case
fact
c
difficil
burden
low
compar
found
control
group
studi
preval
e
coli
pathotyp
eaggec
e
coli
posit
sampl
age
control
group
howev
intimin
posit
sampl
consid
epec
may
repres
addit
pathogen
potenti
nevertheless
c
difficil
occurr
e
coli
also
compar
patient
age
control
group
children
age
agent
found
stool
specimen
one
epec
one
epec
one
eaggec
strain
cohen
et
al
suggest
children
diarrheagen
e
coli
may
repres
gastroenter
case
may
present
stool
asymptomat
children
coincid
viral
infect
conclus
correl
close
result
suggest
detect
e
coli
children
interpret
caution
togeth
microbiolog
result
clinic
observ
parasit
import
caus
childhood
diarrhea
develop
world
carriag
stool
low
children
live
europ
especi
cryptosporidium
spp
g
duodenali
mostli
detect
though
g
duodenali
consid
one
commonest
parasit
human
global
giardiasi
common
notifi
protozoan
diseas
patient
slovenia
nation
institut
public
health
slovenia
cours
giardiasi
less
acut
might
explain
low
preval
studi
encompass
patient
diarrhoea
durat
day
predomin
zoonot
c
parvum
cryptosporidium
spp
human
cryptosporidiosi
slovenia
agreement
studi
conduct
soba
logar
might
reflect
predominantli
rural
origin
patient
one
challeng
task
interpret
gastroenter
etiolog
especi
multitarget
method
appli
clinic
relev
coinfect
studi
sampl
obtain
children
age
contain
one
potenti
relev
pathogen
slightli
report
elsewher
previou
studi
shown
viral
load
clinic
import
least
viral
pathogen
studi
viral
pathogen
clear
role
gastroenter
group
rotavirus
much
lower
ct
valu
virus
pev
bov
hsav
although
ct
valu
differ
target
compar
directli
larg
differ
ct
valu
codetect
virus
differ
mean
ct
valu
target
probabl
suggest
import
viral
load
differ
tabl
would
interest
obtain
absolut
quantit
data
use
new
quantif
method
digit
pcr
concentr
pathogen
bacteria
stool
yet
correl
pathogenesi
sever
diarrhea
ct
valu
evalu
measur
distinct
infect
colon
present
studi
bacteri
burden
stool
substanti
lower
c
difficil
probabl
colon
campylobact
salmonella
sp
probabl
actual
caus
age
howev
preliminari
data
indic
low
bacteri
burden
suggest
colon
need
substanti
recent
mani
new
novel
method
syndrom
approach
present
shown
good
sensit
alreadi
fda
approv
implement
method
coinfect
note
often
order
obtain
balanc
delin
potenti
pathogen
role
diseas
inform
viral
burden
would
help
inclus
control
group
need
howev
power
combin
accur
diagnost
remain
combin
reliabl
analyt
data
conjunct
care
clinic
observ
limit
studi
rel
low
number
control
precis
match
result
signific
differ
age
sex
case
control
observ
boy
predomin
control
group
probabl
due
sexrel
differ
elect
surgic
procedur
inguin
hernia
repair
shown
preval
boy
girl
testicular
retent
surgeri
conclus
studi
provid
support
inform
use
syndrom
approach
diagnost
acut
gastroenter
hospit
children
year
old
test
scheme
includ
rov
novii
adv
astv
campylobact
sp
salmonella
sp
use
approach
etiolog
age
establish
believ
propos
test
scheme
applic
slovenia
also
geograph
region
test
algorithm
evalu
base
epidemiolog
investig
specif
region
molecular
multiplex
method
best
choic
sinc
offer
rapid
specif
sensit
diagnost
import
challeng
copres
sever
agent
interpret
multipl
infect
challeng
could
least
partial
resolv
acquir
quantit
data
viral
target
preval
viral
bacteri
parasit
infect
case
acut
gastroenter
age
group
control
group
tabl
detect
target
next
gener
sequenc
analysi
sampl
recogn
neg
inhous
test
approach
sampl
potenti
age
pathogen
found
highest
nt
aa
ident
genbank
access
number
n
virusspecif
contig
maximum
length
contig
nt
tabl
vesikari
score
specif
clinic
paramet
agent
detect
group
acut
gastroenter
